Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Carcinoma|Stage IV Breast Cancer
Interventions: DRUG: Gemcitabine Hydrochloride|DRUG: Tipifarnib|OTHER: Laboratory Biomarker Analysis
Sponsor: National Cancer Institute (NCI)